Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetes and nephrolithiasis.

Michel Daudon1, Paul Jungers

  • 1Service de Biochimie A, Hôpital Necker-Enfants Malades, APHP, 149, Rue de Sèvres 75743, Paris cedex 15, France. michel.daudon@nck.aphp.fr

Current Diabetes Reports
|February 8, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bacterial biofilms in calcium oxalate kidney stones: Where do we stand?

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Poor compliance of recurrent stone formers to increase their fluid intake in spite of repeated recommendation.

Clinical kidney journal·2026
Same author

Calcium bilirubinate at the Randall's plaque-kidney stone interface: first description.

Journal of nephrology·2026
Same author

Tailored Kidney Stone Prevention Improves Metabolic Risk Factors and Reduces Renal Colic Rate.

Kidney international reports·2026
Same author

An overview of the urinary stone's disease in north of Tunisia over the past decade.

World journal of urology·2025
Same author

Comprehensive analysis of 55,213 stones: understanding common morphological associations advances endoscopic stone recognition and AI integration.

World journal of urology·2025
Same journal

Continuous Glucose Monitoring in Type 2 Diabetes: Clinical Outcomes, Disparities in Access, and Cost-effectiveness.

Current diabetes reports·2026
Same journal

Beyond Inflammation - A Multidisciplinary Approach to Managing Obesity and Cardiometabolic Risk in Inflammatory Bowel Disease.

Current diabetes reports·2026
Same journal

Climate Change and Diabetes Outcomes: Evidence from Climate-Vulnerable Regions.

Current diabetes reports·2026
Same journal

Efficacy and safety of once-weekly basal insulin analogs versus daily basal insulin analogs in adults with type 2 diabetes: a systematic review and meta-analysis.

Current diabetes reports·2026
Same journal

Use of Glucagon-Like Peptide-1 Receptor Agonists in Women with Type 2 Diabetes Before Pregnancy: Addressing the Dilemma in A Real-World Setting.

Current diabetes reports·2026
Same journal

Can Behavioral Interventions Promote Health Equity in Pediatric Type 1 Diabetes? A Narrative Review of Promising Treatments.

Current diabetes reports·2026
See all related articles

Type 2 diabetes increases the risk of uric acid (UA) nephrolithiasis due to low urine pH caused by insulin resistance. This condition is a potential marker for metabolic syndrome and cardiovascular risks.

Area of Science:

  • Nephrology
  • Endocrinology
  • Metabolic Diseases

Background:

  • Type 2 diabetes is linked to a higher incidence of nephrolithiasis, particularly uric acid (UA) stones.
  • Diabetic patients forming UA stones often present with low urine pH, a critical factor for UA crystallization.
  • Insulin resistance, a hallmark of diabetes, is implicated in the development of acidic urine and UA nephrolithiasis.

Purpose of the Study:

  • To investigate the association between insulin resistance and uric acid nephrolithiasis.
  • To highlight UA nephrolithiasis as a potential manifestation of insulin resistance.

Main Methods:

  • The study reviews existing literature on type 2 diabetes, insulin resistance, and uric acid nephrolithiasis.
  • Analysis of the role of urine pH in UA stone formation in diabetic and non-diabetic individuals.

Related Experiment Videos

Main Results:

  • Low urine pH, a consequence of insulin resistance, is the primary driver for uric acid crystallization in diabetic patients.
  • Insulin resistance is a common pathogenic factor in both diabetic and primary UA nephrolithiasis associated with metabolic syndrome.

Conclusions:

  • Uric acid nephrolithiasis should be recognized as a potential indicator of insulin resistance, similar to hyperuricemia.
  • Identifying UA stones warrants screening for metabolic syndrome components to prevent type 2 diabetes and atherosclerosis.
  • Clinicians managing diabetes should be vigilant about the risk of UA stones in their patients.